Stockreport

Response Pharmaceuticals' Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF FALLS CHURCH, Va., April 23, 2024 BUSINESS WIRE Response Pharmaceuticals, Inc ., a clinical stage company focused on weight management and metabolic health in high-risk [Read more]